{"id":"https://openalex.org/W2593661713","doi":null,"title":"Improved \u03b2-Cell Targeting and Therapeutics Using Multivalent Glucagon-Like Peptide-1 (GLP-1) Linked to the \u03b12AR Antagonist Yohimbine (YHB): Evaluating the Binding, Selectivity and Signaling","display_name":"Improved \u03b2-Cell Targeting and Therapeutics Using Multivalent Glucagon-Like Peptide-1 (GLP-1) Linked to the \u03b12AR Antagonist Yohimbine (YHB): Evaluating the Binding, Selectivity and Signaling","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2593661713","mag":"2593661713"},"language":"en","primary_location":{"id":"pmh:oai:repository.arizona.edu:10150/623004","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10150/623004","pdf_url":null,"source":{"id":"https://openalex.org/S4306400271","display_name":"UA Campus Repository (The University of Arizona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138006243","host_organization_name":"University of Arizona","host_organization_lineage":["https://openalex.org/I138006243"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Electronic Dissertation"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018338575","display_name":"Kameswari Ananthakrishnan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kameswari Ananthakrishnan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5018338575"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.05590000003576279,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multivalent-ligands","display_name":"multivalent ligands","score":0.7210000157356262},{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.7110000252723694},{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/yohimbine","display_name":"yohimbine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glp-1-analogues","display_name":"GLP-1 analogues","score":0.718999981880188},{"id":"https://openalex.org/keywords/gpcr-dimerization","display_name":"GPCR dimerization","score":0.5199999809265137},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.6150000095367432},{"id":"https://openalex.org/keywords/receptor-internalization","display_name":"receptor internalization","score":0.7480000257492065},{"id":"https://openalex.org/keywords/betatc3-cells","display_name":"betaTC3 cells","score":0.6700000166893005},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.4519999921321869},{"id":"https://openalex.org/keywords/g-protein-signaling","display_name":"G protein signaling","score":0.6060000061988831},{"id":"https://openalex.org/keywords/ligand-synthesis","display_name":"ligand synthesis","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.7617884874343872},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7518558502197266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6145322322845459},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5952706336975098},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.5686546564102173},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5643531084060669},{"id":"https://openalex.org/C2777676773","wikidata":"https://www.wikidata.org/wiki/Q412226","display_name":"Yohimbine","level":4,"score":0.49811530113220215},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4578498899936676},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.4505808353424072},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4474388360977173},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4382629692554474},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39991167187690735},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3431951403617859},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26317697763442993},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2561963200569153},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24012652039527893},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.23532524704933167},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18531402945518494},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.14565840363502502},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.12854573130607605},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:repository.arizona.edu:10150/623004","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10150/623004","pdf_url":null,"source":{"id":"https://openalex.org/S4306400271","display_name":"UA Campus Repository (The University of Arizona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138006243","host_organization_name":"University of Arizona","host_organization_lineage":["https://openalex.org/I138006243"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Electronic Dissertation"},{"id":"mag:2593661713","doi":null,"is_oa":false,"landing_page_url":"http://arizona.openrepository.com/arizona/handle/10150/623004","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":131,"referenced_works":["https://openalex.org/W146151407","https://openalex.org/W1494276623","https://openalex.org/W1510045468","https://openalex.org/W1518913409","https://openalex.org/W1523913993","https://openalex.org/W1530460707","https://openalex.org/W1584646599","https://openalex.org/W1584861882","https://openalex.org/W1590228841","https://openalex.org/W1598254642","https://openalex.org/W1602157168","https://openalex.org/W1604979407","https://openalex.org/W1964006504","https://openalex.org/W1964477139","https://openalex.org/W1970516311","https://openalex.org/W1976015721","https://openalex.org/W1976596170","https://openalex.org/W1977253764","https://openalex.org/W1979354924","https://openalex.org/W1979499993","https://openalex.org/W1981747731","https://openalex.org/W1984860462","https://openalex.org/W1987044821","https://openalex.org/W1988653285","https://openalex.org/W1989092000","https://openalex.org/W1989391867","https://openalex.org/W1989549783","https://openalex.org/W1991541126","https://openalex.org/W1992052690","https://openalex.org/W1992968276","https://openalex.org/W2003614535","https://openalex.org/W2004415942","https://openalex.org/W2005845037","https://openalex.org/W2006083718","https://openalex.org/W2008427683","https://openalex.org/W2009096988","https://openalex.org/W2009748719","https://openalex.org/W2016766090","https://openalex.org/W2017518223","https://openalex.org/W2019570841","https://openalex.org/W2019655462","https://openalex.org/W2022554776","https://openalex.org/W2023644010","https://openalex.org/W2026444172","https://openalex.org/W2028325091","https://openalex.org/W2028964763","https://openalex.org/W2029214914","https://openalex.org/W2032586081","https://openalex.org/W2035983564","https://openalex.org/W2038463744","https://openalex.org/W2048565142","https://openalex.org/W2049931790","https://openalex.org/W2051826888","https://openalex.org/W2054957275","https://openalex.org/W2058070798","https://openalex.org/W2061187312","https://openalex.org/W2061573662","https://openalex.org/W2061749838","https://openalex.org/W2062319863","https://openalex.org/W2062573090","https://openalex.org/W2062992373","https://openalex.org/W2063255837","https://openalex.org/W2063874715","https://openalex.org/W2066487478","https://openalex.org/W2067765762","https://openalex.org/W2069360712","https://openalex.org/W2071789293","https://openalex.org/W2072570110","https://openalex.org/W2073709031","https://openalex.org/W2074290857","https://openalex.org/W2074501705","https://openalex.org/W2077187510","https://openalex.org/W2080499947","https://openalex.org/W2090309798","https://openalex.org/W2090808078","https://openalex.org/W2091441723","https://openalex.org/W2095327052","https://openalex.org/W2098420292","https://openalex.org/W2099458613","https://openalex.org/W2101508556","https://openalex.org/W2104768673","https://openalex.org/W2106036385","https://openalex.org/W2109093140","https://openalex.org/W2113544353","https://openalex.org/W2114041992","https://openalex.org/W2116916132","https://openalex.org/W2117305868","https://openalex.org/W2117647767","https://openalex.org/W2122220050","https://openalex.org/W2122696108","https://openalex.org/W2126312769","https://openalex.org/W2126851572","https://openalex.org/W2128833727","https://openalex.org/W2129387684","https://openalex.org/W2131112248","https://openalex.org/W2134345431","https://openalex.org/W2137118092","https://openalex.org/W2139532113","https://openalex.org/W2140102874","https://openalex.org/W2142903571","https://openalex.org/W2143523287","https://openalex.org/W2143572858","https://openalex.org/W2145061993","https://openalex.org/W2145736355","https://openalex.org/W2147387884","https://openalex.org/W2148719389","https://openalex.org/W2149803337","https://openalex.org/W2150594488","https://openalex.org/W2151322171","https://openalex.org/W2153134360","https://openalex.org/W2156472431","https://openalex.org/W2156771167","https://openalex.org/W2159668178","https://openalex.org/W2162422341","https://openalex.org/W2163585457","https://openalex.org/W2163672765","https://openalex.org/W2166430034","https://openalex.org/W2166769857","https://openalex.org/W2167056739","https://openalex.org/W2169224435","https://openalex.org/W2169274492","https://openalex.org/W2172313765","https://openalex.org/W2237852169","https://openalex.org/W2274601642","https://openalex.org/W2289361769","https://openalex.org/W2326904657","https://openalex.org/W2335702722","https://openalex.org/W2335830708","https://openalex.org/W2395032676","https://openalex.org/W3122152400","https://openalex.org/W4237887793"],"related_works":["https://openalex.org/W3175709466","https://openalex.org/W3175571246","https://openalex.org/W1005131080","https://openalex.org/W1515972332","https://openalex.org/W166631799","https://openalex.org/W2072570110","https://openalex.org/W2292897014","https://openalex.org/W1500595882","https://openalex.org/W3176647524","https://openalex.org/W3172643460"],"abstract_inverted_index":{"Diabetes":[0],"Mellitus":[1],"(DM)":[2],"is":[3,60,73,86,129,153,198],"a":[4,111,118,147,156,166,188,217,240,298,306,355,439,554],"metabolic":[5],"disorder":[6],"in":[7,57,81,98,114,225,231,322,372,422],"which":[8,65,85],"the":[9,58,87,99,103,130,143,161,202,267,280,325,343,364,400,405],"body":[10],"fails":[11],"to":[12,17,32,39,94,154,170,201,254,295,349,361,363,402,447,474,491,518,546],"achieve":[13],"glucose":[14,29,55],"homeostasis,":[15],"due":[16,348],"either":[18,375],"insulin":[19,23,83,482],"resistance":[20],"or":[21,25,105,377,450],"reduced":[22,389],"secretion":[24,84],"both.":[26],"This":[27],"inadequate":[28],"control":[30],"leads":[31,38],"hyperglycemia":[33],"which,":[34],"if":[35],"left":[36],"unchecked,":[37],"secondary":[40],"complications":[41],"like":[42],"nephropathy,":[43],"neuropathy,":[44],"retinal":[45],"degeneration":[46],"and":[47,78,126,181,205,269,274,319,337,452,508,520,530,550,561],"other":[48],"serious":[49],"conditions.":[50],"In":[51,262,429],"non-disease":[52],"state,":[53],"normal":[54],"level":[56],"blood":[59],"maintained":[61],"by":[62],"pancreatic":[63],"\u03b2-cells,":[64],"secrete":[66],"insulin.":[67],"However,":[68,117],"during":[69,102],"diabetes":[70,108,115],"development,":[71],"there":[72],"loss":[74],"of":[75,90,107,123,132,134,158,244,271,277,293,308,342,351,354,385,391,399,407,431,443],"\u03b2-cell":[76,100,124,135,149,218,299,528],"mass":[77,101,125],"function;":[79],"resulting":[80,421],"decreased":[82],"ultimate":[88],"cause":[89],"hyperglycemia.":[91],"The":[92],"ability":[93,276],"non-invasively":[95],"monitor":[96],"changes":[97],"development":[104],"treatment":[106],"would":[109],"be":[110,544],"significant":[112,315,499],"advance":[113],"management.":[116],"primary":[119],"limitation":[120],"for":[121,141,146,192,477,481,526,557],"analysis":[122],"developing":[127],"dysfunction":[128],"lack":[131],"specificity":[133,145,549],"targeting":[136],"agents.":[137],"Our":[138],"novel":[139],"approach":[140],"achieving":[142],"required":[144],"usable":[148],"targeted":[150,527,562],"contrast":[151],"agent":[152],"target":[155,234],"set":[157],"receptors":[159,211,236,344],"on":[160],"cell":[162],"surface":[163],"that,":[164,213],"as":[165,187,332,334,541],"combination,":[167,220],"are":[168,207],"unique":[169,200],"that":[171,412,467,514,536],"cell.":[172],"Through":[173],"genetic":[174],"screening,":[175],"Glucagon":[176],"Like":[177],"Peptide-1":[178],"Receptor":[179,183],"(GLP-1R)":[180],"\u03b12Adrenergic":[182],"(\u03b12AR)":[184,251],"were":[185,379],"chosen":[186],"potential":[189,525],"molecular":[190],"barcode":[191],"\u03b2-cells":[193,519],"since":[194],"their":[195],"combination":[196,406],"expression":[197],"relatively":[199],"\u03b2-cells.":[203,232],"GLP-1R":[204,376],"\u03b12AR":[206,378],"both":[208,303,394,558],"G-protein":[209],"couple":[210],"(GPCRs)":[212],"apart":[214],"from":[215],"being":[216],"specific":[219],"play":[221],"an":[222,247,255],"important":[223],"role":[224],"regulating":[226],"fundamental":[227],"downstream":[228,416],"signaling":[229,275,417],"pathways":[230],"To":[233],"these":[235,511],"effectively,":[237],"we":[238,288,313],"synthesized":[239],"multivalent":[241],"ligand":[242,401],"composed":[243],"Yohimbine":[245],"(Yhb),":[246],"\u03b12":[248],"adrenergic":[249],"receptor":[250,327],"antagonist,":[252],"linked":[253],"active":[256],"Glucagon-like":[257],"Peptide":[258],"1":[259,335,464],"analog":[260],"(GLP-1\u2087\u208b\u2083\u2086).":[261],"this":[263],"manuscript,":[264],"I":[265],"describe":[266],"synthesis":[268],"characterization":[270],"binding":[272,286,292,318,384,473,487],"selectivity":[273,398],"GLP-1/Yhb":[278,294,317,386,413,434,458,468,515,542],"at":[279,305,329,366,463,495,505],"cellular":[281,548],"level.":[282],"Using":[283,311],"high":[284,290,471,484],"throughput":[285],"assays,":[287],"observed":[289,314,411],"affinity":[291,472,485],"\u03b2TC3":[296],"cells,":[297],"mimetic":[300],"line":[301],"expressing":[302,324,404],"receptors,":[304],"Kd":[307],"~3":[309],"nM.":[310,339,445],"microscopy,":[312],"Cy5-tagged":[316],"rapid":[320],"internalization":[321],"cells":[323,365,373,392,403,420],"complementary":[326],"pair":[328],"low":[330,333,367,496],"concentrations,":[331,497],"nM":[336,507],"5":[338],"When":[340],"one":[341],"was":[345,387],"made":[346],"inaccessible":[347],"presence":[350,430],"saturating":[352],"quantities":[353],"single":[356],"unlabeled":[357],"monomer,":[358],"GLP-1/Yhb-Cy5":[359],"failed":[360],"bind":[362],"concentrations":[368],"(<10":[369],"nM).":[370],"Similarly,":[371],"where":[374],"knocked":[380],"down":[381],"(using":[382],"shRNA),":[383],"significantly":[388,435,460],"(\u2264half":[390],"with":[393,438,498],"receptors),":[395],"indicating":[396],"strong":[397,555],"receptors.":[408],"We":[409],"also":[410],"construct":[414],"modulates":[415],"in\u03b2":[418],"TC3":[419],"enhanced":[423],"Glucose":[424],"Stimulated":[425],"Insulin":[426],"Secretion":[427],"(GSIS).":[428],"stimulatory":[432],"glucose,":[433],"potentiated":[436],"GSIS":[437,462,478],"half-maximal":[440],"effective":[441],"dose":[442],"2.6":[444],"Compared":[446],"GLP-1\u2087\u208b\u2083\u2086":[448,451],"alone":[449],"Yhb":[453],"monomers":[454],"added":[455],"together,":[456],"only":[457,504],"could":[459,469],"potentiate":[461],"nM,":[465],"demonstrating":[466,523],"translate":[470,490],"increased":[475,492],"efficacy":[476],"potentiation.":[479],"Unlike":[480],"secretion,":[483],"divalent":[486],"did":[488],"not":[489],"cAMP":[493],"production":[494],"increases":[500],"above":[501],"baseline":[502],"seen":[503],"10":[506],"higher.":[509],"Nevertheless,":[510],"data":[512],"show":[513],"binds":[516],"selectively":[517],"affects":[521],"signaling,":[522],"its":[524],"imaging":[529,560],"therapy.":[531,563],"Overall,":[532],"our":[533],"work":[534],"indicates":[535],"synthetic":[537],"heterobivalent":[538],"ligands,":[539],"such":[540],"can":[543],"developed":[545],"increase":[547],"sensitivity":[551],"making":[552],"them":[553],"candidate":[556],"noninvasive":[559]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-03-16T00:00:00"}